Saltar al contenido
Merck

Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat.

Anesthesiology (2015-01-13)
Christopher M Peters, Ken-Ichiro Hayashida, Takashi Suto, Timothy T Houle, Carol A Aschenbrenner, Thomas J Martin, James C Eisenach
RESUMEN

Chronic postsurgical pain, a significant public health problem, occurs in 10 to 50% of patients undergoing major surgery. Acute pain induces endogenous analgesia termed conditioned pain modulation (CPM), and the strength of CPM preoperatively predicts the likelihood of chronic postsurgical pain. The relation between CPM and recovery from surgery has not been examined in preclinical models. CPM was assessed in individual rats and correlated with each animal's time course of recovery of hypersensitivity after partial spinal nerve ligation. The role of descending noradrenergic pathways in the spinal cord to mechanisms of CPM and recovery was tested using idazoxan to block noradrenergic receptors or antidopamine β-hydroxylase-conjugated saporin to ablate these pathways. Behavioral hypersensitivity, static weight bearing, and spinal glial activation were measured after partial spinal nerve ligation. The strength of CPM varied over two-fold between individuals and was directly correlated with the slope of recovery from hypersensitivity after surgery (P < 0.0001; r = 0.660). CPM induced the release of norepinephrine in the spinal cord and was partially blocked by intrathecal idazoxan or dopamine β-hydroxylase-saporin. Dopamine β-hydroxylase-saporin also slowed recovery and enhanced spinal glial activation after partial spinal nerve ligation surgery. Ongoing activation of these pathways was critical to sustained recovery because intrathecal dopamine β-hydroxylase-saporin given 7 weeks after recovery reinstituted hypersensitivity, while having no effect in animals without previous surgery. Collectively, these studies provide a clear back-translation from clinical observations of CPM and chronic postsurgical pain and suggest that the ability to engage ongoing descending endogenous noradrenergic signaling may be critical in determining time course of recovery from hypersensitivity after surgery.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Alcohol etílico puro, 200 proof, for molecular biology
Sigma-Aldrich
Alcohol etílico puro, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Alcohol etílico puro, 200 proof, meets USP testing specifications
Sigma-Aldrich
Alcohol etílico puro, 190 proof, for molecular biology
Sigma-Aldrich
o-Xylene, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
o-Xylene, reagent grade, ≥98.0%
Sigma-Aldrich
Capsaicin, ≥95%, from Capsicum sp.
Supelco
o-Xylene, suitable for HPLC, 98%
Sigma-Aldrich
Capsaicin, natural
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
USP
Etanol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Capsaicin, from Capsicum sp., ≥50% (HPLC)
Sigma-Aldrich
o-Xylene, anhydrous, 97%
USP
Capsaicin, United States Pharmacopeia (USP) Reference Standard
Supelco
o-Xylene, analytical standard
Supelco
Etanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin, suitable for fluorescence, BioReagent, ≥90% (HPCE)
Supelco
Capsaicin, analytical standard
Supelco
Capsaicin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
o-Xylene, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin, ≥95% (HPLC), solid
Capsaicin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
p-Xylene-bis(N-pyridinium bromide), ≥95% (TLC)